SAN JOSE, May 14, 2026 /PRNewswire/ -- Resurge Therapeutics, a clinical-stage urology company, today announced positive clinical results from two studies evaluating its proprietary IntraProstatic Drug ...
SAN JOSE, Calif., May 27, 2025 /PRNewswire/ -- Resurge Therapeutics, a privately held therapeutics company, announced promising six-month clinical results from the initial dose cohort of the ongoing ...